EUVIMEDEUVIMED entdecken
Crossref

Suppression of HERV-K Viral Gene Expression in MCF-7 Cells by Doxorubicin: Implications for Breast Cancer Therapy

Buket Çakmak Güner, Merve Yılmazer, Veli Cengiz Özalp

Archives of Current Medical Research · 02.06.2026 · 7 (2) · 401-407

DOI: 10.47482/acmr.1762913 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archives of Current Medical Research, online erschienen am 02.06.2026. Verfasst von Buket Çakmak Güner und 2 weiteren Autor:innen. Die Arbeit nennt 21 Literaturangaben. Gefördert von: This research received no specific grant..

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Breast cancer is one of the most prevalent cancers worldwide and remains a significant cause of mortality among women. Human endogenous retrovirus-K (HERV-K) has been associated with breast cancer progression, yet the effects of chemotherapy on its gene expression are not well understood.

Methods

This study investigated the impact of doxorubicin treatment on the expression of HERV-K gag, pol, and env genes in the MCF-7 breast cancer cell line. MCF-7 cells were treated with varying concentrations of doxorubicin, and total RNA was extracted for gene expression analysis using RT-qPCR. In parallel, apoptosis assays were conducted to evaluate the cytotoxic effects of doxorubicin and determine the IC₅₀ value.

Results

RT-qPCR analysis revealed that doxorubicin exposure significantly reduced the transcriptional levels of the HERV-K gag, pol, and env genes. Apoptosis assays confirmed effective cytotoxicity of doxorubicin, with an IC₅₀ deter-mined to be 1 µg/mL.

Conclusion

These findings suggest that doxorubicin modulates endogenous retroviral activity in breast cancer cells, po-tentially contributing to its therapeutic effects. The downregulation of HERV-K genes may represent a novel mechanism of doxorubicin action. Further research is needed to elucidate the biological significance of HERV-K suppression and evaluate its potential as a biomarker or therapeutic target in breast cancer.

Förderung

  • This research received no specific grant.

Zitieren

APA

Güner, B. Ç., Yılmazer, M., & Özalp, V. C. (2026). Suppression of HERV-K Viral Gene Expression in MCF-7 Cells by Doxorubicin: Implications for Breast Cancer Therapy. Archives of Current Medical Research, 7(2), 401-407. https://doi.org/10.47482/acmr.1762913

Vancouver

Güner BÇ, Yılmazer M, Özalp VC. Suppression of HERV-K Viral Gene Expression in MCF-7 Cells by Doxorubicin: Implications for Breast Cancer Therapy. Archives of Current Medical Research. 2026;7(2):401-407. doi:10.47482/acmr.1762913

BibTeX
@article{Gner2026,
  author = {Güner, Buket Çakmak and Yılmazer, Merve and Özalp, Veli Cengiz},
  title = {Suppression of HERV-K Viral Gene Expression in MCF-7 Cells by Doxorubicin: Implications for Breast Cancer Therapy},
  journal = {Archives of Current Medical Research},
  year = {2026},
  volume = {7},
  number = {2},
  pages = {401--407},
  doi = {10.47482/acmr.1762913}
}
Kostenlos starten →